Antimalarial chemoprophylaxis and treatment in the United States: Limited access and extreme price variability

Anne E Frosch, Beth K Thielen, Jonathan D Alpern, Emily J Walz, Hannah R Volkman, Mackenzie Smith, Danushka Wanduragala, Wilhelmina Holder, Ama Eli Boumi, William M Stauffer

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

To evaluate if cost and availability of antimalarials are barriers to malaria chemoprophylaxis and treatment, we surveyed retail pharmacies in Minneapolis/Saint Paul and New York City on the price and stocking of antimalarials. We demonstrated extreme price variability among pharmacies and limited availability for some recommended antimalarials.

Original languageEnglish (US)
JournalJournal of travel medicine
Volume29
Issue number4
Early online dateAug 3 2021
DOIs
StatePublished - Aug 3 2021

Bibliographical note

© International Society of Travel Medicine 2021. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Keywords

  • Malaria
  • VFR
  • artemether-lumefantrine
  • atovaquone-proguanil
  • chemoprophylaxis
  • pharmacy
  • travel

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

Fingerprint

Dive into the research topics of 'Antimalarial chemoprophylaxis and treatment in the United States: Limited access and extreme price variability'. Together they form a unique fingerprint.

Cite this